Friday, October 09, 2009 10:43:07 PM
Not really. There's not going to be anything here for quite some time if at all. They really took it to the shareholders with the reverse merger crap. Good luck getting any info out of them too. They really don't have any interest in the shareholders.GLTA
Recent XTLB News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/22/2026 08:11:21 PM
- XTL Announces Receipt of Staff Delist Determination from Nasdaq • GlobeNewswire Inc. • 05/22/2026 08:10:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/15/2026 09:09:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/07/2026 12:10:18 PM
- Form NT 20-F - Notification of inability to timely file Form 20-F • Edgar (US Regulatory) • 04/30/2026 08:34:40 PM
- Washington Just Opened the Door to Psychedelic Medicine; This Microcap Already Has a Key • AllPennyStocks.com • 04/29/2026 08:21:50 PM
- XTL Biopharmaceuticals (XTLB) acquisition of Psyga Bio targets psychedelic biotech growth • IH Market News • 04/29/2026 02:47:52 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/29/2026 01:07:41 PM
- XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies • GlobeNewswire Inc. • 04/29/2026 12:58:51 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 08:01:14 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/20/2026 08:11:31 PM
- XTL Biopharmaceuticals Announces ADS Ratio Change • GlobeNewswire Inc. • 03/20/2026 08:10:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/10/2026 08:05:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/27/2026 09:34:26 PM
- XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing • GlobeNewswire Inc. • 02/27/2026 09:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/24/2026 09:05:06 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/23/2026 09:05:27 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/17/2026 09:05:16 PM
- XTL Update on Recent Developments • GlobeNewswire Inc. • 01/29/2026 09:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/28/2026 01:58:46 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/23/2026 09:15:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/23/2026 09:15:09 PM
- XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency • GlobeNewswire Inc. • 01/23/2026 09:10:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/13/2026 09:05:32 PM
